1. Das HK, McPherson J, Bruns GA, Karathanasis SK, Breslow JL. Isolation, characterization, and mapping to chromosome 19 of the human apolipoprotein E gene. J Biol Chem 1985;260:6240-6247.
2. Svobodova H, Kucera F, Stulc T, Vrablík M, Amartuvshin B, Altannavch Ts, et al. Apolipoprotein E gene polymorphism in the Mongolian population. Folia Biol (Praha) 2007;53:138-142.
3. Yousuf FA, Iqbal MP. Review: Apolipoprotein E (Apo E) gene polymorphism and coronary heart disease in Asian populations. Pak J Pharm Sci 2015;28:1439-1444.
4. Kotaska K, Kolarova J, Kotrcova K, Cepova J, Prusa R. Correlation between common genetic variants and risk factors associated with prediction of cardiovascular diseases in dyslipidemic patients. Genet Test Mol Biomarkers 2012;16:210-214.
5. Muller M, Appelman AP, van der Graaf Y, Vincken KL, Mali WP, Geerlings MI. Brain atrophy and cognition: interaction with cerebrovascular pathology? Neurobiol Aging 2011;32:885-893.
7. Hachinski VC, Potter P, Merskey H. Leuko-araiosis: an ancient term for a new problem. Can J Neurol Sci 1986;13:533-534.
8. Raji CA, Lopez OL, Kuller LH, Carmichael OT, Longstreth WT Jr, Gach HM, et al. White matter lesions and brain gray matter volume in cognitively normal elders. Neurobiol Aging 2012;33:834e7-e16.
10. Appelman AP, Exalto LG, van der Graaf Y, Biessels GJ, Mali WP, Geerlings MI. White matter lesions and brain atrophy: more than shared risk factors? A systematic review. Cerebrovasc Dis 2009;28:227-242.
12. Richter N, Michel A, Onur OA, Kracht L, Dietlein M, Tittgemeyer M, et al. White matter lesions and the cholinergic deficit in aging and mild cognitive impairment. Neurobiol Aging 2017;53:27-35.
13. Alaylioglu M, Gezen-Ak D, Dursun E, Bilgiç B, Hanağası H, Ertan T, et al. The association between clusterin and APOE polymorphisms and late-onset alzheimer disease in a Turkish cohort. J Geriatr Psychiatry Neurol 2016;29:221-226.
14. Araki S, Moczulski DK, Hanna L, Scott LJ, Warram JH, Krolewski AS. APOE polymorphisms and the development of diabetic nephropathy in type 1 diabetes: results of case-control and family-based studies. Diabetes 2000;49:2190-2195.
15. Rudilosso S, San Roman L, Blasco J, Hernandez-Perez M, Urra X, Chamorro A. Evaluation of white matter hypodensities on computed tomography in stroke patients using the Fazekas score. Clin Imaging 2017;46:24-27.
19. Schwichtenberg J, Al-Zghloul M, Kerl HU, Wenz H, Hausner L, Frölich L, et al. Late-onset major depression is associated with age-related white matter lesions in the brainstem. Int J Geriatr Psychiatry 2017;32:446-454.
22. Wassink AM, Van Der Graaf Y, Soedamah-Muthu SS, Spiering W, Visseren F. Metabolic syndrome and incidence of type 2 diabetes in patients with manifest vascular disease. Diab Vasc Dis Res 2008;5:114-122.
26. Bea AM, Lamiquiz-Moneo I, Marco-Benedi V, Mateo-Gallego R, Pérez-Calahorra S, Jarauta E, et al. Lipid-lowering response in subjects with the p.(Leu167del) mutation in the
APOE gene. Atherosclerosis 2019;282:143-147.
28. Larifla L, Armand C, Bangou J, Blanchet-Deverly A, Numeric P, Fonteau C, et al. Association of
APOE gene polymorphism with lipid profile and coronary artery disease in Afro-Caribbeans. PLoS One 2017;12:e0181620